Evaxion A/S
A clinical-stage TechBio company developing immunotherapies using an AI platform.
EVAX | US
Overview
Corporate Details
- ISIN(s):
- US29970R3030
- LEI:
- Country:
- United States of America
- Address:
- DR NEERGAARDS VEJ 5F, 0 HOERSHOLM
- Website:
- https://evaxion.ai/
Description
Evaxion A/S is a clinical-stage TechBio company specializing in the development of immunotherapies using its proprietary, clinically validated AI-Immunology™ platform. The platform leverages artificial intelligence and machine learning to decode the human immune system, enabling the rapid discovery and design of novel vaccine targets. Evaxion focuses on creating personalized and precision vaccines for the treatment of cancer and infectious diseases. Its pipeline includes personalized cancer vaccines in clinical development, such as EVX-01 for melanoma, and a preclinical portfolio targeting infectious diseases. The company's technology aims to accelerate the development of tailored vaccine candidates to address critical diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Evaxion A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Evaxion A/S
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Evaxion A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
